on information and promotion is a controversial issue. The rationale of pharmaceutical advertising in medical journals, in particular, is worth examination. In many ways, of course, there is an analogy with daily newspapers, and it seems to me that to have a highly competitive industry buying advertising space in medical journals is no bad thing. Its effect on the economics of medical publishing is self-evident, but what is not always equally appreciated is that it not only helps to keep down the cost of the journal to the reader, but does so without harming the independence of the journal itself.
From the industry side, an advertisement in a medical journal has a guarantee of a selective readership. The industry naturally has a vested interest in ensuring the survival of medical journals, if only to guarantee an independent forum for discussion of the properties of existing and new drugs.
The most recent figures we have are for the year 1975, when the industry spent just over seven million pounds on journal advertising in the UK. This is about 15°o of the industry's total expenditure on information and promotion, and it is interesting that this percentage has remained remarkably constant over the last six or seven years.
Percentage figures can, of course, be very misleading. This is particularly so in a decade in which government has been successful in holding down the prices of pharmaceutical products sold to the NHS; we have some of the lowest prices for medical specialties in western Europe. During the same period, however, the industry has had to face the full effect ofinftation on all its expenses, not excluding journal advertising. Thus the industry has on the one hand had its prices kept down by government pressure, whilst on the other hand its costs have continued to rise. As an example, during the five years [1969] [1970] [1971] [1972] [1973] [1974] journal advertising costs to the pharmaceutical industry have been increased by over 70°0' whilst prices went up by about 25°°i n the same period. In real terms, therefore, the industry's expenditure on information and promotion declined by some 17°0 over this five-year period: this particular statistic has been accepted by the Government as correct.
The industry has always taken the view that the process of informing doctors about its products is as important as the process of innovation itself; for the industry to discover new drugs and then to be inhibited from informing doctors about the discoveries is not only nonsensical but certainly cannot be of ultimate benefit to the patient. The UK ratio of promotion expenditure to sales is significantly lower than in comparable countries in the western world, so by international standards the pharmaceutical industry can hardly be described as being over-lavish with its promotional expenditure.
Companies invest in information and promotion in this manner in order to inform the medical profession about their products, and the expenditure would soon be axed if it were not cost effective. Indeed, any other conclusion would lead one to assume that companies behave irrationally, by deliberately investing in uneconomic promotion. There is, incidentally, a mistaken idea that promotional expenditure invariably and necessarily raises the price of products. A cogent counter-argument is that if the industry is not allowed to spend what it considers necessary, it will have to charge higher prices in order to compensate for the smaller volume of sales.
The other main argument raised by critics is that even if UK pharmaceutical promotion is modest both in volume and cost compared with other countries, the promotion itself is not conducted in a sufficiently professional or objective manner. The industry does not accept this argument and, indeed, has been able to demonstrate that it has gone to considerable lengths in introducing self-imposed controls on the content and quality of advertising. The industry's code of practice, which is drawn up after consultation with the British Medical Association, is policed by a committee under the chairmanship of Sir Joseph Maloney QC. The most recent set of principles for revisions to this code of practice were agreed with Government in April 1977 and will introduce a number of new and quite onerous provisions. The Code of Practice Committee itself is also to have a wider membership, with the appointment of a leading general practitioner and a leading consultant as independent expert members.
The many detailed changes that have now been agreed with government will, I believe, demonstrate very clearly the industry's willingness to accept increased responsibility and further discipline insofar as its promotional methods are concerned.
In conclusion, the industry advertises its products in medical journals because it believes these advertisements are cost effective. It feels that the relationship between the pharmaceutical industry and medical publishers is a healthy one, with advantages to both sides. The reductions sought by the Government in the allowable promotional expenditure as a percentage of sales are likely to have some impact, although it is difficult to predict just what the effect will be. But I believe that advertising by the pharmaceutical industry will continue to be an important factor in the economics of publishing medical journals and in the industry's total promotional effort.
Medical journalsin the future
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The question that we're here to discuss seems to get asked publicly and seriously about once every ten years. Often the question is asked rather more aggressively: 'has the medical journal a future?' The answer tends to be inconclusive, but invariably the debate contains phrases such as 'the exploding number of articles', 'the future access of doctors to new technologies such as videotape, microfiche, and computer print-outs', and so on. The prophesies made by two eminent men -J D Bernal and Sir Theodore Fox, an editor of the Lancet -are always mentioned. These predictions were made fifteen years apart -in 1947 and 1963-and yet both made the same point. This was that the general journal as we know it would disappear, to be replaced by two types of publication: the recorder journal and the newspaper journal. The first would correspond more or less to our presentday specialist journal-the second to a sort of amalgam of the non-original parts of the British Medical Journal, World Medicine, and Pulse. The interesting thing is that none of this has come about; but, on the other hand, why should predictions by experts be any more accurate than those by anybody else? Aristotle, great scientist and philosopher though he was, went wrong with his dictum -accepted for yearsthat, since women were inferior to men, women had fewer teeth. Yet, as Bertrand Russell pointed out, all Aristotle had to do to find out whether he was right or not, was to ask Mrs Aristotle to open her mouth, and to count her teeth.
Having said all that, I should like to give my view -essentially the selfish view of one who gets his living from editing a general medical journal. First of all, I believe that the superiority of the printed word will go on. The convenience of being able to carry an article around, reread difficult passages, recalculate an author's results, will, I believe, never come from a microfiche machine or a television set. The argument and critical scrutiny in a correspondence column could never come to life with a machine-dominated system. I also find it difficult to see people reading book reviews or review articles on a machine, and I cannot see what the gain would be.
My second main point is that I do not believe there has really been an explosion in the number of worthwhile scientific articles. As in R M Pirsig's 'Zen and the Art of Motor-Cycle Maintenance' (1974, The Bodley Head, London), any statement that there has been an explosion ignores the element of quality. Every editior knows that many of the articles submitted to him are rubbish. Every reader knows that some ofthese get through the editorial net and that every journal contains articles which are certainly third-rate. Perhaps one of the most depressing things one can do is to look back through the last ten years ofany journal and see which of the many articles, all carefully screened and processed, have actually affected medical practice. In fact, I believe that any doctor who wants to keep up to date can do so fairly painlessly. He can skim through one or two of the general weekly medical journals, such as the
